28-30
COMMUNICATING WITH HCPS THROUGH AI TAKES FINESSE, FLEXIBILITY AND THE HUMAN TOUCH
While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that peer-to-peer discussion and sharing of opinions that HCPs want and need

34-35
WHY TARIFFS COULD FUEL A NEW ERA OF DOMESTIC PHARMA MANUFACTURING
Pharma is being forced to rethink supply chain resilience from the ground up as tariffs threaten low-cost sourcing